These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 7848920)

  • 1. Protein kinase C isozymes in progressively transformed rat embryo fibroblasts.
    Liao L; Ramsay K; Jaken S
    Cell Growth Differ; 1994 Nov; 5(11):1185-94. PubMed ID: 7848920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased protein kinase C delta in mammary tumor cells: relationship to transformtion and metastatic progression.
    Kiley SC; Clark KJ; Duddy SK; Welch DR; Jaken S
    Oncogene; 1999 Nov; 18(48):6748-57. PubMed ID: 10597283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of protein kinase C epsilon is oncogenic in rat colonic epithelial cells.
    Perletti GP; Folini M; Lin HC; Mischak H; Piccinini F; Tashjian AH
    Oncogene; 1996 Feb; 12(4):847-54. PubMed ID: 8632907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of transformation progression in type 5 adenovirus-transformed rat embryo cells by a cloned protein kinase C beta 1 gene and reversal of progression by 5-azacytidine.
    Su ZZ; Shen R; O'Brian CA; Fisher PB
    Oncogene; 1994 Apr; 9(4):1123-32. PubMed ID: 7510863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of protein kinase C alpha overexpression on A7r5 smooth muscle cell proliferation and differentiation.
    Wang S; Desai D; Wright G; Niles RM; Wright GL
    Exp Cell Res; 1997 Oct; 236(1):117-26. PubMed ID: 9344591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in nuclear protein kinase C-delta holoenzyme, its catalytic fragments, and its activity in polyomavirus-transformed pyF111 rat fibroblasts while proliferating and following exposure to apoptogenic topoisomerase-II inhibitors.
    Dal Pra I; Whitfield JF; Chiarini A; Armato U
    Exp Cell Res; 1999 May; 249(1):147-60. PubMed ID: 10328962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of alpha-protein kinase C neutralizing antibodies and the pseudosubstrate peptide on phosphorylation, migration, and growth of REF52 cells.
    Liao L; Jaken S
    Cell Growth Differ; 1993 Apr; 4(4):309-16. PubMed ID: 8494793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The catalytic domain of PKC-epsilon, in reciprocal PKC-delta and -epsilon chimeras, is responsible for conferring tumorgenicity to NIH3T3 cells, whereas both regulatory and catalytic domains of PKC-epsilon contribute to in vitro transformation.
    Wang QJ; Acs P; Goodnight J; Blumberg PM; Mischak H; Mushinski JF
    Oncogene; 1998 Jan; 16(1):53-60. PubMed ID: 9467942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of expression and activity of four PKC isozymes in confluent and mechanically stimulated UMR-108 osteoblastic cells.
    Geng WD; Boskovic G; Fultz ME; Li C; Niles RM; Ohno S; Wright GL
    J Cell Physiol; 2001 Nov; 189(2):216-28. PubMed ID: 11598907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase C isozyme expression and down-modulation in growing, quiescent, and transformed renal proximal tubule epithelial cells.
    Dong L; Stevens JL; Fabbro D; Jaken S
    Cell Growth Differ; 1994 Aug; 5(8):881-90. PubMed ID: 7986753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transformation by a ras oncogene causes increased expression of protein kinase C-alpha and decreased expression of protein kinase C-epsilon.
    Borner C; Guadagno SN; Hsieh LL; Hsiao WL; Weinstein IB
    Cell Growth Differ; 1990 Dec; 1(12):653-60. PubMed ID: 2288879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts.
    Cacace AM; Guadagno SN; Krauss RS; Fabbro D; Weinstein IB
    Oncogene; 1993 Aug; 8(8):2095-104. PubMed ID: 8336936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional effects of overexpression of protein kinase C-alpha, -beta, -delta, -epsilon, and -eta in the mast cell line RBL-2H3.
    Chang EY; Szallasi Z; Acs P; Raizada V; Wolfe PC; Fewtrell C; Blumberg PM; Rivera J
    J Immunol; 1997 Sep; 159(6):2624-32. PubMed ID: 9300681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective activation of protein kinase C isoforms by v-Src.
    Zang Q; Frankel P; Foster DA
    Cell Growth Differ; 1995 Nov; 6(11):1367-73. PubMed ID: 8562474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase C-epsilon associates with the Raf-1 kinase and induces the production of growth factors that stimulate Raf-1 activity.
    Ueffing M; Lovrić J; Philipp A; Mischak H; Kolch W
    Oncogene; 1997 Dec; 15(24):2921-7. PubMed ID: 9416835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective ceramide binding to protein kinase C-alpha and -delta isoenzymes in renal mesangial cells.
    Huwiler A; Fabbro D; Pfeilschifter J
    Biochemistry; 1998 Oct; 37(41):14556-62. PubMed ID: 9772184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of an ATP binding mutant of PKC-delta inhibits Sis-induced transformation of NIH3T3 cells.
    Li W; Michieli P; Alimandi M; Lorenzi MV; Wu Y; Wang LH; Heidaran MA; Pierce JH
    Oncogene; 1996 Aug; 13(4):731-7. PubMed ID: 8761294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C isoform expression and function in transformed and non-transformed pancreatic acinar cell lines.
    Raffaniello RD; Nam J; Cho I; Lin J; Bao LY; Michl J; Raufman JP
    Biochem Biophys Res Commun; 1998 May; 246(1):166-71. PubMed ID: 9600087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aflatoxin-transformed C3H/10T1/2 cells overexpress protein kinase C and have an altered response to phorbol ester treatments.
    Dunn JA; Faletto MB; Kasper SJ; Gurtoo HL
    Cancer Res; 1992 Feb; 52(4):990-6. PubMed ID: 1737362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGF-induced ERK phosphorylation independent of PKC isozymes in human corneal epithelial cells.
    Xu KP; Dartt DA; Yu FS
    Invest Ophthalmol Vis Sci; 2002 Dec; 43(12):3673-9. PubMed ID: 12454035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.